Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company which engineers targeted immunotherapies, seeking to improve patient outcomes through the power of innate immunity. Affimed’s fit-for-purpose ROCK® platform allows innate immune engagers to be designed for specific patient populations. We are developing single and combination therapies to treat cancers.
To strengthen our highly motivated Program Management Team in Heidelberg, Germany, we are looking for a full-time
(Reference No. OP2205)
The successful candidate will take on full responsibility for the management of a bispecific drug development program in immuno-oncology and will lead execution from early clinical development to program completion by joining an international and diverse cross-functional program team. The position reports into the Senior Program Director and works alongside a Junior Program Manager already assigned to the development program.
The successful candidate will have the unique opportunity to work in a dynamic, highly motivated, multidisciplinary, and collegial team.
For any queries, please contact Susanne Hering (Tel: +49 6221 6743 675, e-mail: email@example.com).